Novo Nordisk A-S
Price & Volume
Stats
See more52W Range | $44.54-$122.24 |
Market Cap | $267.7B |
Shares Short | 25M |
Financials
See moreRevenue (12 Mos) | $311.9B |
Revenue Growth (YoY) | 12.9% |
Gross Profit (12 Mos) | $262.8B |
Diluted EPS | $3.94 |
News
See moreYahoo Finance • 5 hours ago
NOVO DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors a Class Action Lawsuit Has Been Filed Against Novo Nordisk A/S and Encourages Investors to Contact the Firm Before September 30th
Yahoo Finance • 5 hours ago
Novo Nordisk A/S (NVO) Attracts Park Avenue Securities Investment
Yahoo Finance • 8 hours ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO
Yahoo Finance • 11 hours ago
European Equities Traded in the US as American Depositary Receipts Little Changed in Wednesday Trading
About
CEO | Mr. Maziar Mike Doustdar |
CFO | Mr. Karsten Munk Knudsen |
Address | Novo Alle 1, Bagsvaerd, Denmark, 2880 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 78,387 |
